The global digital breast tomosynthesis market is expected to grow from USD 8.83 billion 2017 to USD 13.47 billion by the end of 2024 at a Compound Annual Growth Rate (CAGR) of 6.22%.
“Need to detect early symptoms of breast canceris one of the factors largely attributing to the growth of digital breast tomosynthesis market globally”
The factors attributing to the growth of the market are need to detect early symptoms of breast cancer, higher level of sensitivity and specificity in comparison to conventional 2d mammography, and invasive cancer detection and reduced false negative recall. However, some factors such as and limited reimbursement options may hinder the market growth. The global digital breast tomosynthesis market is expected to showcase the opportunities such as dbt equipment providers offering software and hardware upgrades for full film digital mammography systems, and increasing demand in asia pacific market. In the near future, the market may face the possible challenges in the growth due to and expensive equipment. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the global digital breast tomosynthesis market market.
On the basis of application, the global digital breast tomosynthesis market is studied across Diagnostic Centres and Hospitals.
On the basis of geography, the global digital breast tomosynthesis market is studied across Americas, (United States, Brazil, Canada, Mexico, and Argentina) Europe, Middle East & Africa, (United Kingdom, Germany, France, Saudi Arabia, United Arab Emirates, Italy, and Russia) and Asia-Pacific (China, Japan, India, and Australia).
“ADANI: The potential growing player for the global digital breast tomosynthesis market”
The key players profiled in the global digital breast tomosynthesis market are ADANI, Fujifilm Corporation, GE Healthcare, Hologic, Inc., I.M.S. Internazionale Medico Scientifica S.r.l., Nanjing Jusha Commercial &Trading Co,Ltd., Perlove Medical, Planmed Oy, Siemens Healthcare GmbH, Yesmed, Inc., Zhangjiagang Bestran Technology Co.,Ltd., and iCAD, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the global digital breast tomosynthesis market.
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the global digital breast tomosynthesis market.
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the global digital breast tomosynthesis market.
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the global digital breast tomosynthesis market.
5. Competitive Assessment & Intelligence: Provides exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global digital breast tomosynthesis market.
Summary:
Get latest Market Research Reports on Digital Breast Tomosynthesis . Industry analysis & Market Report on Digital Breast Tomosynthesis is a syndicated market report, published as Global Digital Breast Tomosynthesis Market - Premium Insight, Industry Trends, FPNV Positioning Matrix, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2024 (Q2 2018 Update). It is complete Research Study and Industry Analysis of Digital Breast Tomosynthesis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.